These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10393486)

  • 1. Serum growth hormone measurements in clinical practice: An audit of performance from the UK National External Quality Assessment scheme.
    Seth J; Ellis A; Al-Sadie R
    Horm Res; 1999; 51 Suppl 1():13-9. PubMed ID: 10393486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of performance of assays for serum growth hormone in the United Kingdom (UK): evidence from the UK external quality assessment scheme, 1980-1987.
    Seth J; Hanning I; Bacon RR; Hunter WM
    Clin Chim Acta; 1988 May; 174(2):171-83. PubMed ID: 3383442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone stimulation testing in both short and normal statured children: use of an immunofunctional assay.
    Mauras N; Walton P; Nicar M; Welch S; Rogol AD
    Pediatr Res; 2000 Nov; 48(5):614-8. PubMed ID: 11044480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Problematic determination of serum growth hormone: experience from external quality assurance surveys 1998-2003.
    Mörsky P; Tiikkainen U; Ruokonen A; Markkanen H
    Scand J Clin Lab Invest; 2005; 65(5):377-86. PubMed ID: 16081360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. External quality assessment of hormone determinations.
    Sturgeon CM
    Best Pract Res Clin Endocrinol Metab; 2013 Dec; 27(6):803-22. PubMed ID: 24275192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variety in growth hormone determinations due to use of different immunoassays and to the interference of growth hormone-binding protein.
    Ebdrup L; Fisker S; Sørensen HH; Ranke MB; Orskov H
    Horm Res; 1999; 51 Suppl 1():20-6. PubMed ID: 10393487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human growth hormone (GH) immunoassay: standardization and clinical implications.
    Carrozza C; Lapolla R; Canu G; Annunziata F; Torti E; Baroni S; Zuppi C
    Clin Chem Lab Med; 2011 May; 49(5):851-3. PubMed ID: 21361855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Italian program of External Quality Control for chromogranin A (CgA) assay: performance evaluation of CgA determination.
    Verderio P; Dittadi R; Marubini E; Pizzamiglio S; Gion M; De Apollonia L; Paradiso A;
    Clin Chem Lab Med; 2007; 45(9):1244-50. PubMed ID: 17663633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Problems with GH assays and strategies toward standardization.
    Bidlingmaier M
    Eur J Endocrinol; 2008 Dec; 159 Suppl 1():S41-4. PubMed ID: 18819944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors modifying growth hormone estimates in immunoassays.
    Fisker S; Orskov H
    Horm Res; 1996; 46(4-5):183-7. PubMed ID: 8950618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detecting and solving the interference of pregnancy serum, in a GH immunometric assay.
    Dias ML; Vieira JG; Abucham J
    Growth Horm IGF Res; 2013; 23(1-2):13-8. PubMed ID: 23206731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of access ultrasensitive human growth hormone assay to monoclonal antibody-based immunoradiometric assay.
    Iwahara K; Tanabe C; Maekawa M
    Clin Chim Acta; 2007 Feb; 376(1-2):248-9. PubMed ID: 17126825
    [No Abstract]   [Full Text] [Related]  

  • 13. Why do immunoassays for tumour markers give differing results?--a view from the UK National External Quality Assessment Schemes.
    Sturgeon CM; Seth J
    Eur J Clin Chem Clin Biochem; 1996 Sep; 34(9):755-9. PubMed ID: 8891529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance evaluation of a fully automated immunoassay for the detection of human growth hormone on the Elecsys immunoassay system.
    Van Helden J; Hermsen D; Von Ahsen N; Bidlingmaier M
    Clin Lab; 2014; 60(10):1641-51. PubMed ID: 25651709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National audit of cerebrospinal fluid testing.
    Holbrook I; Beetham R; Cruickshank A; Egner W; Fahie-Wilson M; Keir G; Patel D; Watson I; White P
    Ann Clin Biochem; 2007 Sep; 44(Pt 5):443-8. PubMed ID: 17761029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UK external quality assessment scheme for immunoassays in endocrinology.
    MacKenzie F; Bullock DG; Ratcliffe JG
    Ann Ist Super Sanita; 1991; 27(3):453-7. PubMed ID: 1809064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central laboratory reassessment of IGF-I, IGF-binding protein-3, and GH serum concentrations measured at local treatment centers in growth-impaired children: implications for the agreement between outpatient screening and the results of somatotropic axis functional testing.
    Hauffa BP; Lehmann N; Bettendorf M; Mehls O; Dörr HG; Stahnke N; Steinkamp H; Said E; Ranke MB;
    Eur J Endocrinol; 2007 Nov; 157(5):597-603. PubMed ID: 17984239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone assays: current methodologies and their limitations.
    Bidlingmaier M; Strasburger CJ
    Pituitary; 2007; 10(2):115-9. PubMed ID: 17429592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. International standards for growth hormone.
    Bristow AF
    Horm Res; 1999; 51 Suppl 1():7-12. PubMed ID: 10393485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of growth hormone-binding proteins on serum growth hormone measurements.
    Jan T; Shaw MA; Baumann G
    J Clin Endocrinol Metab; 1991 Feb; 72(2):387-91. PubMed ID: 1991809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.